Both in Pharmaceuticals
Prelude Therapeutics Incorporated vs Arcturus Therapeutics Holdings
Over the past year PRLD returned −2.5% and ARCT returned +18.6%; their daily moves had a correlation of 0.18.
PRLD −2.5% ARCT +18.6%Growth of $1, one year, split-adjusted
| Metric | PRLD | ARCT |
|---|---|---|
| Price | $3.88 | $11.03 |
| Market cap | $309.6M | $313.5M |
| Today | −5.37% | −9.22% |
| 1 month | +2.4% | −16.5% |
| 6 months | −17.4% | +27.8% |
| Year to date | +33.8% | +79.9% |
| 1 year | +145.6% | +16.8% |
| Revenue growth (YoY) | — | −89.5% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −244.1% | −803.8% |
| P/E (TTM) | — | — |
| Price / sales | 13.8× | 10.7× |
| Net cash | $151.8M | $191.5M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 114.9% |
| Short % of float | 13.2% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).